The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 36-month results.
Shunji Takahashi
Honoraria - Novartis
Research Funding - Novartis
Takuji Iwase
No relevant relationships to disclose
Norio Kohno
No relevant relationships to disclose
Takashi Ishikawa
No relevant relationships to disclose
Seung Jin Kim
No relevant relationships to disclose
Mitsuchika Hosoda
No relevant relationships to disclose
Jun Horiguchi
No relevant relationships to disclose
Hideko Yamauchi
No relevant relationships to disclose
Yasuo Hozumi
No relevant relationships to disclose
Morihito Okada
No relevant relationships to disclose
Masao Fukunaga
No relevant relationships to disclose
Shinzaburo Noguchi
No relevant relationships to disclose